Risk score for prediction of 10 year dementia risk in individuals with type 2 diabetes: a cohort study
- PMID: 24622366
- PMCID: PMC4429783
- DOI: 10.1016/S2213-8587(13)70048-2
Risk score for prediction of 10 year dementia risk in individuals with type 2 diabetes: a cohort study
Abstract
Background: Although patients with type 2 diabetes are twice as likely to develop dementia as those without this disease, prediction of who has the highest future risk is difficult. We therefore created and validated a practical summary risk score that can be used to provide an estimate of the 10 year dementia risk for individuals with type 2 diabetes.
Methods: Using data from two longitudinal cohorts of patients with type 2 diabetes (aged ≥60 years) with 10 years of follow-up, we created (n=29,961) and validated (n=2413) the risk score. We built our prediction model by evaluating 45 candidate predictors using Cox proportional hazard models and developed a point system for the risk score based on the size of the predictor's β coefficient. Model prediction was tested by discrimination and calibration methods. Dementia risk per sum score was calculated with Kaplan-Meier estimates.
Findings: Microvascular disease, diabetic foot, cerebrovascular disease, cardiovascular disease, acute metabolic events, depression, age, and education were most strongly predictive of dementia and constituted the risk score (C statistic 0·736 for creation cohort and 0·746 for validation cohort). The dementia risk was 5·3% (95% CI 4·2-6·3) for the lowest score (-1) and 73·3% (64·8-81·8) for the highest (12-19) sum scores.
Interpretation: To the best of our knowledge, this is the first risk score for the prediction of 10 year dementia risk in patients with type 2 diabetes mellitus. The risk score can be used to increase vigilance for cognitive deterioration and for selection of high-risk patients for participation in clinical trials.
Funding: Kaiser Permanente Community Benefit, National Institute of Health, Utrecht University, ZonMw, and Fulbright.
Copyright © 2013 Elsevier Ltd. All rights reserved.
Figures
Comment in
-
Prediction of dementia in people with diabetes.Lancet Diabetes Endocrinol. 2013 Nov;1(3):164-5. doi: 10.1016/S2213-8587(13)70091-3. Epub 2013 Aug 20. Lancet Diabetes Endocrinol. 2013. PMID: 24622354 No abstract available.
Similar articles
-
Development and Validation of the RxDx-Dementia Risk Index to Predict Dementia in Patients with Type 2 Diabetes and Hypertension.J Alzheimers Dis. 2016;49(2):423-32. doi: 10.3233/JAD-150466. J Alzheimers Dis. 2016. PMID: 26519436
-
Midlife risk score for the prediction of dementia four decades later.Alzheimers Dement. 2014 Sep;10(5):562-70. doi: 10.1016/j.jalz.2013.05.1772. Epub 2013 Sep 10. Alzheimers Dement. 2014. PMID: 24035147
-
Risk score prediction model for dementia in patients with type 2 diabetes.Eur J Neurol. 2018 Jul;25(7):976-983. doi: 10.1111/ene.13642. Epub 2018 May 2. Eur J Neurol. 2018. PMID: 29603513 Clinical Trial.
-
Depression, stroke, and dementia in patients with myocardial infarction.Dan Med J. 2018 Apr;65(4):B5423. Dan Med J. 2018. PMID: 29619929 Review.
-
Diabetes and dementia: Clinical perspective, innovation, knowledge gaps.J Diabetes Complications. 2022 Nov;36(11):108333. doi: 10.1016/j.jdiacomp.2022.108333. Epub 2022 Oct 5. J Diabetes Complications. 2022. PMID: 36240668 Free PMC article. Review.
Cited by
-
Association of time in range with cognitive impairment in middle-aged type 2 diabetic patients.BMC Endocr Disord. 2024 Nov 8;24(1):241. doi: 10.1186/s12902-024-01772-5. BMC Endocr Disord. 2024. PMID: 39516758 Free PMC article.
-
A Polysocial Approach in Exploring Racial and Ethnic Differences in Dementia and Cognitive Decline Among U.S. Older Adults: Health and Retirement Study.Innov Aging. 2024 Aug 28;8(10):igae078. doi: 10.1093/geroni/igae078. eCollection 2024. Innov Aging. 2024. PMID: 39416701 Free PMC article.
-
A High-Carbohydrate Diet Induces Cognitive Impairment and Promotes Amyloid Burden and Tau Phosphorylation via PI3K/Akt/GSK-3β Pathway in db/db Mice.Biomedicines. 2024 Jul 31;12(8):1701. doi: 10.3390/biomedicines12081701. Biomedicines. 2024. PMID: 39200168 Free PMC article.
-
Risk factors and metabolomics of mild cognitive impairment in type 2 diabetes mellitus.Front Mol Biosci. 2024 Apr 18;11:1341290. doi: 10.3389/fmolb.2024.1341290. eCollection 2024. Front Mol Biosci. 2024. PMID: 38698772 Free PMC article.
-
A Nomogram Including Total Cerebral Small Vessel Disease Burden Score for Predicting Mild Vascular Cognitive Impairment in Patients with Type 2 Diabetes Mellitus.Diabetes Metab Syndr Obes. 2024 Apr 6;17:1553-1562. doi: 10.2147/DMSO.S451862. eCollection 2024. Diabetes Metab Syndr Obes. 2024. PMID: 38601039 Free PMC article.
References
-
- Strachan MW, Reynolds RM, Marioni RE, Price JF. Cognitive function, dementia and type 2 diabetes mellitus in the elderly. Nat Rev Endocrinol. 2011;7:108–14. - PubMed
-
- Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol. 2006;5:64–74. - PubMed
-
- Carrillo MC, Brashear HR, Logovinsky V, et al. Can we prevent Alzheimer’s disease? Secondary “prevention” trials in Alzheimer’s disease. Alzheimers Dement. 2013 - PubMed
-
- Dehnel T. The European dementia prevention initiative. Lancet Neurol. 2013;12:227–8. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
